Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening

Prenatal Diagnosis

Volumn 21, Issue 7, 2001, Pages 553-557

  Ryall, Richard G ^a   Callen, David ^a   Cocciolone, Robert ^a   Duvnjak, Amra ^b   Esca, Renata ^a   Frantzis, Niki ^a   Gjerde, Elizabeth M ^a   Haan, Eric A ^a   Hocking, Trudy ^a   Sutherland, Grant ^a   Thomas, David W ^a   Webb, Fiona ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Antenatal screening; Down syndrome; Karyotypes

Indexed keywords

ARTICLE; CHROMOSOME MOSAICISM; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FETUS WASTAGE; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; INHERITANCE; KARYOTYPE; KARYOTYPE 45,X; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRIPLOIDY; TRISOMY 13; TRISOMY 18;

DOWN SYNDROME; FEMALE; GENETIC SCREENING; HUMANS; KARYOTYPING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; RISK FACTORS; SOUTH AUSTRALIA;

EID: 0034872121     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.108     Document Type: Article

References (20)

1. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome
2. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype
3. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: Result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population
4. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results
5. Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative European study on 52965 amniocenteses
6. Same day diagnosis of Down's syndrome and sex in single cells using multiplex fluorescent PCR
7. Prenatal screening for Downs's syndrome with use of maternal serum markers
8. Triploid partial molar pregnancy detected through maternal serum alphafetoprotein and HCG screening
9. Chromosomal abnormality rates at amniocentesis and live-born infants
10. Elevated second-trimester maternal urine free beta-human chorionic gonadotropin levels in Asian pregnancies with fetal chromosomal abnormalities
11. Prenatal diagnosis of de novo interstitial deletion of proximal 4q by maternal serum screening for Down syndrome
12. Fluorescent in situ hybridization and second-trimester sonographic anomalies: Uses and limitations
13. Prenatal screening using maternal serum alphafetoprotein, human chorionic gonadotropin, and unconjugated estriol: Two-year experience in a health maintenance organization
14. Improved performance in a prenatal screening programme for Down's syndrome incorporating serum free hCG subunit analyses
15. Counselling implications of chromosomal abnormalities other than trisomy 21 detected through maternal serum screening programme
16. Epidemiology of Down syndrome in South Australia 1960-89
17. De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: Clinical significance and distribution of breakpoints
18. Multiple marker screening test: Identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy
19. 'Dual positivity' for neural tube defects and Down syndrome at maternal serum screening: Gestational outcome